Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology

被引:20
|
作者
Sibony, Mathilde [1 ]
Vieillefond, Annick [2 ]
机构
[1] Univ Paris 06, Hop Tenon, AP HP, Serv Anat & Cytol Pathol, F-75020 Paris, France
[2] Univ Paris 05, Hop Cochin, AP HP, Serv Anat & Cytol Pathol, F-75014 Paris, France
关键词
Nonclear cell renal cell carcinoma; Papillary renal cell carcinoma; Oncocytoma; Chromophobe renal cell carcinoma; Renal carcinomas associated with Xp11.2 translocations; REST; Miscellaneous tumours; unclassified carcinoma;
D O I
10.1016/j.annpat.2008.07.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Non clear cell renal cell carcinomas represent almost 20% of all renal neoplasms. Their classification is continuously being adjusted according to new cytogenetic and molecular data. Since molecular techniques are expensive, diagnosis still relies on morphological and immuno-histochemical criteria detailed hereby. Papillary renal cell carcinomas are the most important group and its classification is more and more complex. It encompasses low-grade papillary carcinomas (type 1 papillary renal cell carcinoma, oncocytic papillary renal cell carcinoma) and high-grade papillary carcinomas (type 2 papillary renal cell carcinoma, juvenile papillary carcinoma corresponding to renal carcinoma associated with Xp11.2 translocations and unclassified carcinomas). Mucinous tubular and spindle cell carcinoma and tubulocystic carcinoma are new entities, actually considered by some authors as Low-grade papillary carcinomas. The so-called carcinoma of collecting ducts of Bellini and renal medullary carcinoma should be considered as intrarenal urothelial carcinoma or as high-grade papillary or unclassified carcinoma. Sarcomatoid carcinoma derives from morphological progression of any type of renal cell carcinoma. The group of oncocytomas/chromophobe renal cell carcinomas can be considered as a spectrum from benign (oncocytoma) to malignant neoplasm (chromophobe renal cell carcinoma). They are sometimes encountered in oncocytomatosis or familial. Birt-Hogg-Dubbe syndrome in which tumoral cells may have hybrid features. Angiomyolipoma is usually a benign mesenchymatous neoplasm, that can be sporadic or familial (tuberous sclerosis). In the latter situation, some cases of epithelioid angiomyolipoma (potentially malignant) have been described. Renal epithelial and stromal tumors (REST) is a new concept gathering two benign mixed mesenchymal and epithelial tumors: cystic nephroma and mixed epithelial. and stromal tumors (MEST). (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:381 / 401
页数:21
相关论文
共 50 条
  • [31] Non-Clear Cell Renal Cell Carcinoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 8 - 10
  • [32] PD-L1 expression in non-clear cell renal cell carcinoma.
    Fay, Andre P.
    Callea, Marcella
    Gray, Kathryn P.
    Thai Huu Ho
    Song, Jiaxi
    Carvo, Ingrid
    Lampron, Megan E.
    Stanton, Melissa L.
    McDermott, David F.
    Atkins, Michael B.
    Freeman, Gordon J.
    Hirsch, Michelle S.
    Signoretti, Sabina
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
    Singla, Nirmish
    Nirschl, Thomas
    Obradovic, Aleksandar
    Shenderov, Eugene
    Lombardo, Kara A.
    Liu, Xiaopu
    Pons, Alice
    Zarif, Jelani
    Rowe, Steven P.
    Trock, Bruce J.
    Hammers, Hans J.
    Bivalacqua, Trinity
    Pierorazio, Phillip
    Deutsch, Julie S.
    Lotan, Tamara L.
    Taube, Janis M.
    Ged, Yasser
    Gorin, Michael A.
    Allaf, Mohamad E.
    Drake, Charles G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [34] A novel preoperative inflammatory marker prognostic score in patients with clear cell and non-clear cell renal cell carcinoma.
    Sekar, Rishi Robert
    Patil, Dattatraya
    Pearl, Jeff
    Baum, Yoram
    Kucuk, Omer
    Harris, Wayne B.
    Carthon, Bradley
    Alemozaffar, Mehrdad
    Filson, Christopher Paul
    Ogan, Kenneth
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [35] Multinucleated tumor cells in clear cell renal cell carcinoma
    Pacheco, Richard R.
    Binboga Kurt, Busem
    Kosemehmetoglu, Kemal
    Rothrock, Aimi T.
    Lightle, Andrea
    Akgul, Mahmut
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 (06) : 603 - 611
  • [36] The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
    Monjaras-Avila, Cesar U.
    Lorenzo-Leal, Ana C.
    Luque-Badillo, Ana C.
    D'Costa, Ninadh
    Chavez-Munoz, Claudia
    Bach, Horacio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [37] Necrosis and Tumor Grading in Clear Cell Renal Cell Carcinoma
    Dagher, Julien
    Delahunt, Brett
    Rioux-Leclercq, Nathalie
    Egevad, Lars
    Coughlin, Geoff
    Dunglison, Nigel
    Gianduzzo, Troy
    Kua, Boon
    Malone, Greg
    Martin, Ben
    Preston, John
    Pokorny, Morgan
    Wood, Simon
    Samaratunga, Hemamali
    MODERN PATHOLOGY, 2017, 30 : 220A - 220A
  • [38] Complexity of Tumor Vasculature in Clear Cell Renal Cell Carcinoma
    Qian, Chao-Nan
    Huang, Dan
    Wondergem, Bill
    Teh, Bin Tean
    CANCER, 2009, 115 (10) : 2282 - 2289
  • [39] Necrosis and Tumor Grading in Clear Cell Renal Cell Carcinoma
    Dagher, Julien
    Delahunt, Brett
    Rioux-Leclercq, Nathalie
    Egevad, Lars
    Coughlin, Geoff
    Dunglison, Nigel
    Gianduzzo, Troy
    Kua, Boon
    Malone, Greg
    Martin, Ben
    Preston, John
    Pokorny, Morgan
    Wood, Simon
    Samaratunga, Hemamali
    LABORATORY INVESTIGATION, 2017, 97 : 220A - 220A
  • [40] Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma
    Montironi, R.
    Mazzucchelli, R.
    Scarpelli, M.
    Lopez-Beltran, A.
    Cheng, L.
    HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (12) : 1555 - 1566